Chargement en cours...
Pomalidomide desensitization in a patient hypersensitive to immunomodulating agents
Despite progressive treatments with tandem stem-cell transplantation, patients with incurable myeloma eventually succumb to relapsed or refractory disease if left untreated. Promising agents such as proteasome inhibitors and immunomodulating imide drugs (imids), including the newer-generation agent...
Enregistré dans:
| Publié dans: | Curr Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576472/ https://ncbi.nlm.nih.gov/pubmed/28874903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3572 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|